<DOC>
	<DOCNO>NCT01872897</DOCNO>
	<brief_summary>This study conduct assess effectiveness Compound Sodium Alginate Double Action Chewable Tablets compare placebo acidic reflux event esophagus patient diagnose Gastroesophageal Reflux Disease ( GERD ) .</brief_summary>
	<brief_title>Compound Sodium Alginate Double Action Chewable Tablets 4-hour Esophageal pH Study GERD Patients</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Alginate , aluminium hydroxide , magnesium trisilicate , sodium bicarbonate drug combination</mesh_term>
	<mesh_term>Alginic acid</mesh_term>
	<criteria>meet diagnostic criterion GERD GERD history frequent episode GERDrelated symptom last 2 month prior study screen . The patient must also meet follow criterion : 1 . The main symptom heartburn ( burn feel back breast bone ) and/or acid reflux . Symptoms persist occur repeatedly 2 month ; 2 . As assessed Investigator screen question patient , frequency occurrence heartburn ≥ 3 days/week score severity heartburn general ≥ moderate within 3 week screen Patients history drug , solvent alcohol abuse ( weekly alcohol intake ≥ 140g ) . Patients suffer cardiac chest pain within last year . Patients suffer recent , significant unexplained weight loss 6 Kg last 6 month . Female patient childbearing potential , duration study , either unwilling unable take adequate contraceptive precaution unwilling sexually abstinent . Pregnancy lactate mother . Patients history and/or symptom profile suggestive following : gastrointestinal ( GI ) disease , erosive GERD ( Los Angeles [ LA ] classification grade CD ) , Barrett 's esophagus , acute peptic ulcer and/or ulcer complication , ZollingerEllison syndrome , gastric carcinoma , pyloric stenosis , oesophageal gastric surgery , intestinal obstruction , current pernicious anaemia , indication Hpylori eradication therapy , know gastrointestinal bleeding ( hematochezia hematemesis ) within last 3 month , severe disease major body system . Patients observe screen hiatus hernia diameter exceed 3cm . Patients take anticholinesterase drug , traditional Chinese medicine treat gastrointestinal disease , ulcerlmin misoprostol preparation within 7 day prior screen throughout study . Patients take PPIs 10 day prior screen , prokinetics H2 antagonists 5 day prior screen systemic glucocorticosteroids , nonsteroidal antiinflammatory drug ( NSAIDs , except low dose aspirin give cardioprotection ) 3 consecutive day PPIbased triple quadruple therapy eradication Hpylori last 28 day . Patients take require take macrolide antibiotic , erythromycin , azithromycin , day screen . Patients difficulty swallow . Patients know hypophosphataemia , phenylketonuria hypercalcaemia . Patients severe constipation , history intestinal obstruction . In opinion Investigator , patient damage heart kidney function patient require low sodium diet .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Gastroesophageal Reflux Disease</keyword>
	<keyword>GERD</keyword>
	<keyword>Acid reflux</keyword>
	<keyword>Compound Sodium Alginate Double Action Chewable Tablet</keyword>
	<keyword>Gaviscon Double Action Tablets</keyword>
</DOC>